Although Unproven, Some Advocates Believe the Technology Can Save Both Time and Money The current approach to drug development has not served the industry well. Fewer drugs are being approved, even as ...

Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.

In silico modeling is becoming a valuable and accurate prediction tool, despite its early, spotty reputation. The increase in information from metabolomics, proteomics, and genomics projects, plus ...

This webinar examines the benefits of combining Liver-on-a-chip with in silico modeling to explore clinical PK predictions of specific reference drugs, including investigations into the intrinsic ...

Simulations Plus' silico software boosts non-animal drug development and drives growth. Read here for an investment analysis ...

AUSTIN, Texas and TOKYO, Nov. 27, 2025 /PRNewswire/ -- According to DataM Intelligence, the In-Silico Clinical Trials Market Size was USD 3.76 billion in 2023, increased to USD 3.95 billion in 2024, ...

AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...

Multi-omics analysis uncovers prognostic biomarkers and tumor ecosystem dynamics during sequential neoadjuvant treatment of dose-limiting chemotherapy combined with sintilimab for non-small cell lung ...